NCT03360032 Comparing Measurements Made in an Incremental Shuttle Walk Test and a Cardiopulmonary Exercise Test in Patients With IPF Status UNKNOWN Phase N/A
NCT03287414 Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis Status TERMINATED Phase PHASE2
NCT03281200 Chart Review Study to Describe the Clinical Profile of Idiopathic Pulmonary Fibrosis (IPF) Patients Treated With Nintedanib (OFEV®) in Real-world Practice in Spain Status COMPLETED Phase N/A
NCT03274544 Clinical Trial of Chinese Herbal Medicine for Idiopathic Pulmonary Fibrosis (IPF) Status TERMINATED Phase NA
NCT03268915 Idiopathic Pulmonary Fibrosis (IPF) and the 3 Minutes Sit-to-stand Test Status COMPLETED Phase NA
NCT03261037 A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period Status COMPLETED Phase NA
NCT03258801 Pirfenidone as Bridging Therapy for Lung Transplant in Patients Suffering From Idiopathic Pulmonary Fibrosis Status WITHDRAWN Phase N/A
NCT03229343 Impact of a Systematic Palliative Care on Quality of Life, in Advanced Idiopathic Pulmonary Fibrosis. Status UNKNOWN Phase NA
NCT03222648 Structured Exercise Training Programme in Idiopathic Pulmonary Fibrosis Status COMPLETED Phase NA
NCT03215147 Prevalence and Impact on Quality of Life of Airway Disease in Patients With Idiopathic Pulmonary Fibrosis Status UNKNOWN Phase N/A
NCT03208933 Open-label Study to Assess the Effectiveness of Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis (IPF). Status COMPLETED Phase PHASE3
NCT03183570 Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT Status COMPLETED Phase EARLY_PHASE1
NCT03171870 Characteristics and Health Related Quality of Life in Idiopathic Pulmonary Fibrosis Status UNKNOWN Phase NA
NCT03142191 A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis Status TERMINATED Phase PHASE2
NCT03115619 Quality of Life Study in Participants With IPF Under Pirfenidone Treatment Status COMPLETED Phase N/A
NCT03104322 Patient-reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary Fibrosis Status COMPLETED Phase NA